Corticosteroids for community-acquired pneumonia: time to act!
- PMID: 18638361
- PMCID: PMC2575557
- DOI: 10.1186/cc6940
Corticosteroids for community-acquired pneumonia: time to act!
Abstract
The use of corticosteroids for the treatment of community-acquired pneumonia has been reported for almost 50 years. A recent systematic analysis of the relevant literature suggested that corticosteroids reduce the critical illness associated with community-acquired pneumonia. There is little doubt that a prolonged administration of a moderate dose of corticosteroids may alleviate the systemic inflammatory response and subsequent organ dysfunction in severe infection. Whether these favorable effects on morbidity may translate into better survival and quality of life needs to be addressed in additional adequately powered randomized controlled trials.
Comment on
-
The role of corticosteroids in severe community-acquired pneumonia: a systematic review.Crit Care. 2008;12(3):R76. doi: 10.1186/cc6922. Epub 2008 Jun 11. Crit Care. 2008. PMID: 18547407 Free PMC article.
References
-
- Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, Fine J, Krichevsky A, Delude RL, Angus DC, GenIMS Investigators Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med. 2007;167:1655–1663. doi: 10.1001/archinte.167.15.1655. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical